Literature DB >> 22086373

Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses.

Heba W Z Khella1, Nicole M A White, Hala Faragalla, Manal Gabril, Mina Boazak, David Dorian, Bishoy Khalil, Hany Antonios, Tian Tian Bao, Maria D Pasic, R John Honey, Robert Stewart, Kenneth T Pace, Georg A Bjarnason, Michael A S Jewett, George M Yousef.   

Abstract

Metastasis results in most of the cancer deaths in clear cell renal cell carcinoma (ccRCC). MicroRNAs (miRNAs) regulate many important cell functions and play important roles in tumor development, metastasis and progression. In our previous study, we identified a miRNA signature for metastatic RCC. In this study, we validated the top differentially expressed miRNAs on matched primary and metastatic ccRCC pairs by quantitative polymerase chain reaction. We performed bioinformatics analyses including target prediction and combinatorial analysis of previously reported miRNAs involved in tumour progression and metastasis. We also examined the co-expression of the miRNAs clusters and compared expression of intronic miRNAs and their host genes. We observed significant dysregulation between primary and metastatic tumours from the same patient. This indicates that, at least in part, the metastatic signature develops gradually during tumour progression. We identified metastasis-dysregulated miRNAs that can target a number of genes previously found to be involved in metastasis of kidney cancer as well as other malignancies. In addition, we found a negative correlation of expression of miR-126 and its target vascular endothelial growth factor (VEGF)-A. Cluster analysis showed that members of the same miRNA cluster follow the same expression pattern, suggesting the presence of a locus control regulation. We also observed a positive correlation of expression between intronic miRNAs and their host genes, thus revealing another potential control mechanism for miRNAs. Many of the significantly dysregulated miRNAs in metastatic ccRCC are highly conserved among species. Our analysis suggests that miRNAs are involved in ccRCC metastasis and may represent potential biomarkers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086373     DOI: 10.1007/s13277-011-0255-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  62 in total

Review 1.  Metastamirs: a stepping stone towards improved cancer management.

Authors:  Nicole M A White; Eman Fatoohi; Maged Metias; Klaus Jung; Carsten Stephan; George M Yousef
Journal:  Nat Rev Clin Oncol       Date:  2010-11-02       Impact factor: 66.675

Review 2.  MicroRNAs and the cell cycle.

Authors:  María José Bueno; Marcos Malumbres
Journal:  Biochim Biophys Acta       Date:  2011-02-18

Review 3.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

4.  Frequent mutation of BAP1 in metastasizing uveal melanomas.

Authors:  J William Harbour; Michael D Onken; Elisha D O Roberson; Shenghui Duan; Li Cao; Lori A Worley; M Laurin Council; Katie A Matatall; Cynthia Helms; Anne M Bowcock
Journal:  Science       Date:  2010-11-04       Impact factor: 47.728

Review 5.  Tumor biology and prognostic factors in renal cell carcinoma.

Authors:  David S Finley; Allan J Pantuck; Arie S Belldegrun
Journal:  Oncologist       Date:  2011

6.  Expression of focal adhesion kinase gene and invasive cancer.

Authors:  T M Weiner; E T Liu; R J Craven; W G Cance
Journal:  Lancet       Date:  1993-10-23       Impact factor: 79.321

7.  Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.

Authors:  K A Honeycutt; Z Chen; M I Koster; M Miers; J Nuchtern; J Hicks; D R Roop; J M Shohet
Journal:  Oncogene       Date:  2006-03-06       Impact factor: 9.867

8.  Tumor self-seeding by circulating cancer cells.

Authors:  Mi-Young Kim; Thordur Oskarsson; Swarnali Acharyya; Don X Nguyen; Xiang H-F Zhang; Larry Norton; Joan Massagué
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

9.  Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development.

Authors:  Flavia Pichiorri; Sung-Suk Suh; Alberto Rocci; Luciana De Luca; Cristian Taccioli; Ramasamy Santhanam; Wenchao Zhou; Don M Benson; Craig Hofmainster; Hansjuerg Alder; Michela Garofalo; Gianpiero Di Leva; Stefano Volinia; Huey-Jen Lin; Danilo Perrotti; Michael Kuehl; Rami I Aqeilan; Antonio Palumbo; Carlo M Croce
Journal:  Cancer Cell       Date:  2010-10-19       Impact factor: 31.743

10.  Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.

Authors:  Yoshimasa Saito; Jeffrey M Friedman; Yoshitomo Chihara; Gerda Egger; Jody C Chuang; Gangning Liang
Journal:  Biochem Biophys Res Commun       Date:  2008-12-29       Impact factor: 3.322

View more
  32 in total

1.  MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6.

Authors:  Xiangyang Zhang; Yuqiang Nie; Yanlei Du; Jie Cao; Bo Shen; Yuyuang Li
Journal:  Tumour Biol       Date:  2012-05-12

2.  miR-335 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells through direct suppression of BCL-W.

Authors:  Kefeng Wang; Xiaonan Chen; Yunhong Zhan; Weiguo Jiang; Xuefeng Liu; Xia Wang; Bin Wu
Journal:  Tumour Biol       Date:  2015-04-08

3.  Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.

Authors:  Nicole M White-Al Habeeb; Ashley Di Meo; Andreas Scorilas; Fabio Rotondo; Olena Masui; Annetta Seivwright; Manal Gabril; Andrew H A Girgis; Michael A Jewett; George M Yousef
Journal:  Clin Exp Metastasis       Date:  2015-06-03       Impact factor: 5.150

4.  S100A11 is a potential prognostic marker for clear cell renal cell carcinoma.

Authors:  Manal Gabril; Hala Girgis; Andreas Scorilas; Fabio Rotondo; Samantha Wala; Georg A Bjarnason; Qiang Ding; Andrew Evans; Eriny Tawedrous; Maria Pasic; Antonio Finelli; Sahar Al-Haddad; George M Yousef
Journal:  Clin Exp Metastasis       Date:  2016-01       Impact factor: 5.150

5.  miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinoma.

Authors:  Guanghui Hu; Peng Lai; Min Liu; Liang Xu; Zhuifeng Guo; Huan Liu; Wei Li; Gangchun Wang; Xudong Yao; Junhua Zheng; Yunfei Xu
Journal:  Tumour Biol       Date:  2014-08-15

6.  MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1.

Authors:  Cai Lv; Zhiming Bai; Zhenxiang Liu; Pengcheng Luo; Jie Zhang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

7.  Quantitative assessment of the association between microRNA-499 rs3746444 A/G polymorphism and cancer risk.

Authors:  Hongzhi Sun; Qing Li; Tao Yang; Wei Wang
Journal:  Tumour Biol       Date:  2013-11-21

Review 8.  Transforming growth factor-β signalling in renal fibrosis: from Smads to non-coding RNAs.

Authors:  Patrick Ming-Kuen Tang; Ying-Ying Zhang; Thomas Shiu-Kwong Mak; Philip Chiu-Tsun Tang; Xiao-Ru Huang; Hui-Yao Lan
Journal:  J Physiol       Date:  2018-06-28       Impact factor: 5.182

9.  Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.

Authors:  Guillermo de Velasco; Aedín C Culhane; André P Fay; A Ari Hakimi; Martin H Voss; Nizar M Tannir; Pheroze Tamboli; Leonard J Appleman; Joaquim Bellmunt; W Kimryn Rathmell; Laurence Albiges; James J Hsieh; Daniel Y C Heng; Sabina Signoretti; Toni K Choueiri
Journal:  Oncologist       Date:  2017-02-20

10.  Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma.

Authors:  Weijun Liu; Hanxiang Chen; Nathan Wong; Wesley Haynes; Callie M Baker; Xiaowei Wang
Journal:  Cancer Lett       Date:  2017-02-28       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.